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Effect ofAcetaminophen on Glutathione Levels
in RatTestis and Lung
L. Micheli, D. Cerretani, A.I. Fiaschi, G. Giorgi, M.R. Romeo, and
F.M. Runci
Institute of Pharmacology, University of Siena, Italy
Glutathione (GSH) levels in rat testis and lung after oral administration (3 g/kg) of acetaminophen (APAP) were studied. At the administered dose
APAP is present in each organ and influences the GSH levels. APAP value of 114 pg/g was obtained in testis at 6 hr (peak time); in the lung the Cmax
was 92 p/g at 8 hr and this value lasted several hours longer than that in testis. GSH levels are also affected differently in the organs studied after
APAP administration; the lungs seem to be the primary organ undergoing the depleting action of APAP. This process could not only cause toxicity,
but also predispose those organs to the action of toxic compounds responsible for specific pathologies.-Environ Health Perspect Vol 102(Suppl
9):63-64 (1994)
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Introduction
The drug acetaminophen (APAP) has
become widely studied because of the
specificity in causing serious liver injury
after overdose in humans; it remains one of
the most frequently chosen drugs in suicide
and in suicide attempts (1). Occasionally,
injury is also noted in people taking only
recommended therapeutic doses of the
drug. Following therapeutic doses, APAP is
primarily eliminated as a nontoxic conju-
gate of glucuronic acid and sulfate. In a
minor pathway, APAP is converted in a
purported N-acetyliminoquinone (2-3),
which is normally detoxified by conjuga-
tion (4,6) with hepatic glutathione (GSH).
Following an overdose ofAPAP, the capac-
ity for its removal by hepatic conjugation
with sulfate or glucuronide is exceeded and
the extent of formation of the toxic
metabolite is increased (6). Mechanistic
studies largely in animals show that P450
cytochromes convert APAP into a reactive
metabolite, N-acetyl-p-benzoquinoneimine
(NAPQI) that indiscriminately arylates
macromolecules throughout the cell. This
irreversible binding of APAP metabolite
closely parallels the degree of the subse-
quent tissue damage and thus has come to
be viewed as the initiating event in a com-
plex process that can culminate in cell
death (7). NAPQI is a highly reactive
metabolite that combines directly with
GSH and appears to be responsible for ini-
tiating liver damage, although research
continues to establish the exact nature and
formation mechanism of the toxic species
(8). Very little is known about APAP dis-
tribution in other organs and its relation-
ship with GSH contained there. Having
this goal, we measured GSH content and
APAP concentration in testis and lungs of
rats after oral administration. It must be
pointed out that none ofthe 94 rats, which
were observed for 2 weeks, died after the
administration ofthe above dose.
Materials and Methods
One hundred thirty-four male albino rats
(Wistar strain), weighing 170 to 200 g,
maintained for 2 weeks on balanced diet
(Mil, Morini, S. Polo d'Enza, Italy) with free
access to water and kept under a standard-
ized temperature of about 20C and divided
in six groups each with its control group,
were used. The treated animals received
orally APAP suspended in arabic gum (2%
in distillated water) at the dose of3 g/kg; the
control group received vehicle only. At 4, 6,
8, 12, 192, and 336 hr after the drug
administration, but at the same hour each
day (16:00), the rats were killed by decapita-
tion and exsanguinated (9). Immediately
lung and testis were removed, weighed,
washed in saline, and homogenized properly
in phosphate-EDTA buffer, pH 7.4. One ml
of 25% trichloroacetic acid was added to 1
ml of the homogenate and then centrifuged
at 2000g for 10 min at 0° C.
In the supernatants GSH levels were
determined by the method of Tietze and
expressed as nmole/mg of protein (10).
The protein concentration was determined
by the method ofLowry (11). All the pro-
cedures were performed at 00C. The differ-
ences between GSH means were evaluated
by the Student's two-tailed t-test. No sta-
tistical differences were observed among
the control groups; thus, they were col-
lected in a single organ pool.
In the homogenate of testis and lungs,
APAPwasdeterminedbyHPLCmethod (12).
Results and Discussion
In Table 1 the maximum APAP concentra-
tion (pg/g tissue) in lungs and testis and
Table 1. Maximum concentration and peak time in rat
testis and lung after APAP administration (3 g/kg os).
Cmax, Peaktime
Organ pg/g tissue hr
Testis 114 6
Lung 92 8
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Table 2. APAP concentration as percent of Cm5. (100%) in rat testis and lung after APAP oral administration
(3g/kg).
Organ Time, hr
0 2 4 6 8 12 192 336
Testis 0 4 6 100 37 28 0 0
Lung 0 50 84 100 95 0 0
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Figure 1. Kinetics of APAP in rat testis (a) and lung (b)
after oral administration (3 g/kg). Each point represents
the meanvalueoffiveanimalswith standard deviation.
the peak time are reported. Table 2 shows
the APAP concentration as percent Cma,
(100%). Figure 1 shows the time-course of
APAP. Figure 2 reports the GSH levels
variations in two studied organs of rats
after oral APAP administration.
It is evident that, at the administered
dose, APAP is present in each organ in dif-
ferent amounts and with various peak
times. From the obtained results one can
say that APAP administration on GSH lev-
els influences these levels according to the
organ considered. The lung appears to be
the organ that primarily evidences the
depleting action of APAP. Our data
demonstrate that APAP at the studied dose
exerts not only a specific toxicity, but can
also predispose those organs to the action
of toxic agents and thus indirectly can be
the cause ofspecific pathologies.
The experiments presented here suggest
that APAP (and NAPQI) can be added to
the list of compounds which can disrupt
Ca2+ homeostasis and that this may be a
common pathway ofcell toxicity for agents
which affect the redox status of cells, as
seen previously (13).
It is obvious that depletion of GSH by
NAPQI would allow a greater proportion
of the metabolite to interact with protein
tiol groups. Jollow et al. (5) were the first
to observe the association between the
extent of covalent binding of APAP
metabolites to protein and the degree of
liver necrosis. The binding of NAPQI to
cysteinyl groups ofproteins leads to loss of
available protein thiols, a feature of
NAPQI toxicity observed by Moore et al
(14). NAPQI can directly or indirectly oxi-
dize NADPH and, concomitantly, deplete
GSH by conjugation and/or oxidation.
Mitochondria immediately release their
sequestered Ca2+ upon exposure to
NAPQI. There are several mechanisms
which might account for this effect;
NAPQI could have a direct protonophoric
action and/or precipitate Ca2+ release by
affecting the redox status ofmitochondrial
thiols. The oxidation of pyridine nucleo-
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Figure 2. Time course of GSH levels after APAP oral
administration (3 g/kg) in (a) rat testis and (b) lung. The
control value is equal to 100. The dotted lines represent
in every picture te upper and the lower limits (standard
deviation of the control). The number of animals is
reported in parentheses. ***p<0.001.
tides could also account for this release,
although significant NADPH oxidation
occurred after Ca2+ release was initiated.
Nevertheless, sustained or secondary mito-
chondrial Ca2+ efflux is probably caused by
NAPQI-induced oxidation of pyridine
nucleotides.
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